BKM 120

DRUG2 trials

Sponsors

Vanderbilt-Ingram Cancer Center, SCRI Development Innovations, LLC

Conditions

Advanced Prostate CancerMetastatic Breast Cancer

Phase 1

PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer

CompletedNCT01248494

Vanderbilt-Ingram Cancer CenterMetastatic Breast Cancer

Start: 2010-11-30End: 2016-05-31Updated: 2016-07-25

Phase 2

Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel

WithdrawnNCT02035124

SCRI Development Innovations, LLCAdvanced Prostate Cancer

Start: 2014-04-30End: 2015-01-31Updated: 2016-02-11